{
    "organizations": [],
    "uuid": "487d5cf59fbf3f488fc0acb467102fde4331ddad",
    "author": "",
    "url": "https://www.reuters.com/article/samsung-biologic-accounting/samsung-biologics-said-jv-partner-biogen-to-exercise-option-by-late-june-idUSL3N1SO5XH",
    "ord_in_thread": 0,
    "title": "Samsung BioLogics said JV partner Biogen to exercise option by late June",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "SEOUL, May 18 (Reuters) - Samsung BioLogics said on Friday that its joint venture partner Biogen would exercise its call option to increase its stake to 50 pct minus one share in Samsung Bioepis.\nBiogen sent a letter to the South Korean biotech drug maker that it planned to use the option by June 29, BioLogics said in a regulatory filing. (Reporting by Ju-min Park and Joori Roh; Editing by Grant McCool)\n ",
    "published": "2018-05-18T01:46:00.000+03:00",
    "crawled": "2018-05-18T02:06:02.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "seoul",
        "may",
        "reuters",
        "samsung",
        "biologics",
        "said",
        "friday",
        "joint",
        "venture",
        "partner",
        "biogen",
        "would",
        "exercise",
        "call",
        "option",
        "increase",
        "stake",
        "pct",
        "minus",
        "one",
        "share",
        "samsung",
        "bioepis",
        "biogen",
        "sent",
        "letter",
        "south",
        "korean",
        "biotech",
        "drug",
        "maker",
        "planned",
        "use",
        "option",
        "june",
        "biologics",
        "said",
        "regulatory",
        "filing",
        "reporting",
        "park",
        "joori",
        "roh",
        "editing",
        "grant",
        "mccool"
    ]
}